TOCA | tickerfilter.com

Fundamental analysis

30%

Profitability 35%

Dept financing 45%

Liquidity 12%

Performance 27%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0 0%

1 Month

0 0%

3 Months

0 0%

6 Months

0 0%

1 Year

0 0%

2 Year

0 0%

Key data

Stock price

$1.26

P/E Ratio

N/A

DAY RANGE

$1.26 - $1.26

EPS

-$2.38

52 WEEK RANGE

$0.42 - $6.77

52 WEEK CHANGE

-$79.74

MARKET CAP

30.138 M

YIELD

N/A

SHARES OUTSTANDING

23.919 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

$18,019,016

AVERAGE 10 VOLUME

$530,372

AVERAGE 30 VOLUME

$481,103

Company detail

CEO: Martin J. Duvall
Region: US
Website: http://www.tocagen.com
Employees: 29
IPO year: -

Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA.

TOCA - Tocagen Inc.